JNJ•benzinga•
Johnson & Johnson To Present Data From Phase 3 ASTRO Study Of TREMFYA SC Induction Therapy At ECCO; Says Study Achieved Primary And All Secondary Endpoints At Week 12 In Ulcerative Colitis Patients
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 21, 2025 by benzinga